CDK2 and ovarian carcinoma: Several studies revealed, counterintuitively, that CDK2 participates in DNA repair [7,233], and CCNE-amplified ovarian carcinomas rely on CDK2 for DNA repair through homologous recombination, its inhibition compromises replication fork repair [7].